Switch to optionsXpress for advanced derivatives trading & earn 50 commission-free trades.
Advertisement
SureTrader Stock Hero Advertisement
Home > Boards > US OTC > Miscellaneous >

Rich Pharmaceuticals Inc. (RCHA)

RCHA RSS Feed
Add RCHA Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator stervc, Reptos, sunspotter, Nadia, NUMBER7, Imarket13
Search This Board:
Last Post: 3/28/2015 10:25:08 AM - Followers: 172 - Board type: Free - Posts Today: 2





http://www.richpharmaceuticals.com/

 
  
 

 
http://www.otcmarkets.com/stock/RCHA/profile
 

 
RCHA Patent for Treatment of Hodgkin’s Lymphoma
http://www.richpharmaceuticals.com/wp-content/uploads/2014/10/Rich-10_13_14-HL-Patent-Ownership-Rights.pdf
Under terms of the agreement, Rich Pharmaceuticals, Inc. will obtain complete ownership and all interest in the indication, patents and intellectual property related to treatment of Hodgkin’s Lymphoma, utility patent application number 61998397, entitled COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS FOR THE TREATMENT OF HODGKIN’S LYMPHOMA.
 
RCHA Recent News
http://finance.yahoo.com/news/rich-pharmaceuticals-announces-completion-manufacture-144500701.html
Rich Pharmaceuticals Announces Completion of the Manufacture of RP-323 Study Drug in Connection with Obtaining FDA's Final Approval of The Investigational New Drug (IND) Application For The Treatment of Acute Myelocytic Leukemia
 
BEVERLY HILLS, Calif., Feb. 4, 2015 /PRNewswire/ -- Rich Pharmaceuticals, Inc. (RCHA) ("Rich" or the "Company"), a clinical-stage biotechnology company focused on developing innovative therapies in oncology, announced today that it has competed a GMP clinical batch of RP-323 study drug that was manufactured at the state-of-the-art Wuxi Apptec Biopharmaceutical's facility based in Shanghai, China.  This new batch of RP-323 represents a new second-generation compound with improved product usability and stability.  Rich Pharmaceuticals developed the new formulation and all regulatory required testing methods in 2014 and transferred the proprietary technology successfully to Wuxi Apptec for the GMP production of RP-323.  Currently, the new study drug is in the final examination stage at Wuxi Apptec and is expected to be shipped to clinical sites starting mid-February 2015 for the upcoming planned clinical trials.   
 
Rich Pharmaceuticals submitted its Investigational New Drug (IND) Application for a Phase 2 multi-center study to evaluate the safety and efficacy of RP-323 in patients with AML and MDS in October 2014.  In connection with the IND, Rich Pharmaceuticals was required to manufacture sufficient quantities of RP-323 under GMP.
 
"We believe RP-323 has best-in-class potential and holds significant promise for patients suffering from AML and MDS," said Ben Chang, Rich Pharmaceuticals' Chief Executive Officer.  Mr. Chang further stated, "We are especially excited to have a partner in the manufacture of RP-323 of the high caliber of Wuxi Apptec.  We expect to pursue the approval of the IND promptly and to be in clinical studies in the very near term."
 
About Rich Pharmaceuticals:
 
Rich Pharmaceuticals, Inc. (RCHA) is a biopharmaceutical company developing a treatment for Acute Myelocytic Leukemia (AML)/white blood cell elevation, Hodgkin's Lymphoma and other blood related diseases.  Rich Pharmaceuticals' goal is to extend refractory patients life expectancy and increase quality of life.  Rich Pharmaceuticals' primary development stage product candidate, RP-323, is being designed to treat blood and cancer related diseases through non-evasive outpatient facilities.  Find out more at www.richpharmaceuticals.com
 
WuXi PharmaTech, Inc. trades on the NYSE in the area of $40.00 per share under the ticker of WX with a $2.8 Billion Market Cap:
http://finance.yahoo.com/q/ks?s=WX+Key+Statistics
http://finance.yahoo.com/q?s=wx&ql=1
http://www.wuxiapptec.com/

 

 
Below is the indicated Product Pipeline for RCHA:
Quote:


http://www.richpharmaceuticals.com/science-and-technology/pipeline/


Here is a key piece from the news as to how it applies:
Quote:


http://finance.yahoo.com/news/rich-pharmaceuticals-announces-completion-manufacture-144500701.html
"We believe RP-323 has best-in-class potential and holds significant promise for patients suffering from AML and MDS," said Ben Chang, Rich Pharmaceuticals' Chief Executive Officer.  Mr. Chang further stated, "We are especially excited to have a partner in the manufacture of RP-323 of the high caliber of Wuxi Apptec.  We expect to pursue the approval of the IND promptly and to be in clinical studies in the very near term."


Courtesy of Sibware: 
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110569310 
RCHA RP-323:Potential Market=$1 to 2 Billion/Year US.$5 Billion Worldwide. 

Business Overview 

The Company is developing RP-323 (formerly called PD-616) for the treatment of Acute Myelogenous Leukemia (AML), and to cause elevation of white blood cells (WBC) in patients depleted of these elements due to various conditions. 

Clinical Studies in Acute Myelocytic Leukemia 

Based on the known properties of RP-323, it was first administered in a pilot study in China, either alone or in combination with standard drugs, and caused temporary remission of AML in some patients’ refractory to standard therapy. Several patients recovered sufficiently with RP-323 treatment to return to their normal occupations, symptom-free. Interest in these findings led to a Phase I investigator-sponsored trial in 35 patients by a leading oncologist at a leading cancer hospital in New Jersey, the University of Medicine and Dentistry of New Jersey (UMDNJ). 

Market Opportunities 

AML 

It is estimated that 40,000 people in the US have AML and an additional 14,000 are diagnosed annually with a yearly death rate of over 10,000. Based on this incidence,the potential market for RP-323 for the treatment of AML is approximately $1 to 2 billion peak sales annually in the US and more than $5 billion worldwide.
 



RCHA Key DD Posts:
 
Key RCHA & WX:NYSE Relationship
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110555124
 
Respectfully, again, key with the Authorized Shares
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110551465
 

 
RCHA NEWS
 
http://finance.yahoo.com/q/h?s=RCHA+Headlines
http://www.richpharmaceuticals.com/category/news/
 

 
RCHA SEC FILINGS
https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001504389&owner=exclude&count=40
 

 
http://www.richpharmaceuticals.com/contact-us/

Contact Us
9595 Wilshire Boulevard, Ste. 900
Beverly Hills, CA 90045

P: 424.230.7001
F: 424.230.7003

E: info@richpharmaceuticals.com
 

 

 
Daily View

 
 
 
Weekly View

 
 
 
3 Month Daily View

 
 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
RCHA
Current Price
Volume:
Bid Ask Day's Range
Wiki
RCHA News: Current Report Filing (8-k) 03/16/2015 02:23:21 PM
RCHA News: Rich Pharmaceuticals, Inc. Names Chittima Sirijerachai, MD as Principal Investigator for Upcoming AML Clinical Trials 03/12/2015 09:35:00 AM
RCHA News: Current Report Filing (8-k) 03/06/2015 04:38:32 PM
RCHA News: Amended Current Report Filing (8-k/a) 03/02/2015 11:46:30 AM
RCHA News: Amended Quarterly Report (10-q/a) 02/25/2015 03:01:47 PM
PostSubject
#6618  Sticky Note "in the face of the massive gains we sunspotter 03/17/15 05:07:01 AM
#6506  Sticky Note Here's a real link to the FDA figures Reptos 03/13/15 12:14:15 PM
#3430  Sticky Note DRUG TRIALS START AROUND FEB. 15TH HUGE NEWS IMMINENT! vegasvic 02/11/15 11:12:06 AM
#2921  Sticky Note RCHA Expects FDA Orphan Drug Fast Track Approval… stervc 02/07/15 10:05:01 AM
#6992   Since the Dumping started the first week of onthegreen 03/28/15 10:25:08 AM
#6991   Float is 1.4 Billion only. ace1mc 03/28/15 09:54:00 AM
#6990   I am buying again WTF....who cares when the vhgier 03/27/15 02:03:09 PM
#6989   Slowly bleeding out. RCHA ....sad Axeman 03/27/15 02:02:31 PM
#6988   LMFAO! TRIPS AGAIN! Solid Stock....only 30 billion more onthegreen 03/27/15 10:37:12 AM
#6987   I told you they were dumping too much stockdarockk 03/27/15 10:13:32 AM
#6986   Almost time to finish the week strong!! Go artdo63 03/27/15 09:17:45 AM
#6985   But isn't .0010 a better buy than .0014 Homebrew 03/27/15 07:28:37 AM
#6984   Bought. no jinx please. chocolate_dip 03/27/15 02:35:08 AM
#6982   Anybody still holding wouldnt sell anyway. Better rondrty 03/27/15 02:31:40 AM
#6981   LMAO. This has been dumped since the fake onthegreen 03/26/15 04:27:45 PM
#6980   Funny thing about $RCHA today is it's been ospreyeye 03/26/15 03:40:09 PM
#6979   RCHA slowly bleeding out. I would say a Axeman 03/26/15 02:44:04 PM
#6978   Suckers are born every day LMAO... EmptyBones 03/26/15 12:44:17 PM
#6977   Seems Ihub is down and so is RCHA valleyview 03/26/15 11:38:48 AM
#6976   Why does Yahoo state that the float is 662.14M? Ididmyresearch 03/26/15 11:34:24 AM
#6975   LMAO....They've sold 5 billion already in the past onthegreen 03/26/15 11:21:56 AM
#6974   why the heck would anyone buy a stock valleyview 03/26/15 08:23:14 AM
#6972   About 20 million sitting at the bid, less JDUB 03/25/15 01:36:28 PM
#6971   Shhhh....Their watching ER Dude 03/25/15 01:12:10 PM
#6970   Because the PR from yesterday meant nothing. tiller 03/25/15 11:35:12 AM
#6969   Fluff news of Letter of intent. That Axeman 03/25/15 11:33:28 AM
#6966   Why is today's volume very weak compared to yesterday's? beletskiyisaac 03/25/15 11:11:47 AM
#6963   RCHA down bid getting lower !! 37 billion valleyview 03/25/15 09:49:31 AM
#6962   ETRADE show $RCHA at $.0015 now Go $RCHA Pistol Pete 03/25/15 09:22:26 AM
#6961   Anti takeover strategy = 37 billion AS. They relativity 03/25/15 06:37:31 AM
#6960   agree,never buy a stock of 37 billion AS .... valleyview 03/25/15 12:36:19 AM
#6959   Well the good news is that FDA does khmerican 03/24/15 09:47:12 PM
#6958   Wait it out, imo it will rise up. HarryMorris 03/24/15 09:43:01 PM
#6957   "The letter of intent" -a red flag. Stock Predictor 03/24/15 09:36:44 PM
#6956   Yeah, All that volume and it couldn't close Arnold25764 03/24/15 08:16:25 PM
#6955   LOL, that fake wall is a billion deep, onthegreen 03/24/15 07:34:44 PM
#6954   Oh by the way, a letter of intent plmlf 03/24/15 06:37:47 PM
#6953   Check out huge AH buy, fake wall on apparentamateur 03/24/15 06:35:37 PM
#6952   testing ????? Rich Pharmaceuticals (RCHA) mick 03/24/15 06:32:43 PM
#6950   Gap to 15 tomorrow morning! apparentamateur 03/24/15 04:31:30 PM
#6949   As I said earlier, we would close at 0.0012. tiller 03/24/15 04:17:56 PM
#6948   I believe that as well. JDUB 03/24/15 03:38:46 PM
#6947   I bet ETRADE wall is fake on the 13s. OTC Knight 03/24/15 03:27:46 PM
#6946   today portfolio looking all red.... Richiter 03/24/15 03:25:02 PM
#6945   LMFAO....Back to trips! Another 150 million shares sold onthegreen 03/24/15 03:20:23 PM
#6944   Vol after all that dump trips are coming lipster 03/24/15 03:19:45 PM
#6943   Thats completely backwards. Its volume precedes price as stockdarockk 03/24/15 02:59:41 PM
#6942   I went to yahoo to see the actual Ididmyresearch 03/24/15 02:36:45 PM
#6941   nice volume! let's go RCHA kragdason 03/24/15 01:45:43 PM
#6940   I slapped the ask! Lets go!! artdo63 03/24/15 01:26:16 PM
#6939   Price precedes Volume!! GO $RCHA! Arnold25764 03/24/15 01:24:03 PM
#6938   Yes she is looking nice. Building! Building!! artdo63 03/24/15 01:22:43 PM
#6937   Getting some nice volume here today!! Hopefully we Arnold25764 03/24/15 01:22:05 PM
#6936   Lets Roll! Time to get paid!! Go RCHA artdo63 03/24/15 01:21:19 PM
PostSubject